Lung lobe

Belousov A.S.

Белоусов А.С.

ГБУЗ «ГП №5 ДЗМ», ГБУЗ «КДЦ №4 ДЗМ»

SPIN РИНЦ: 5615-5795

Доля легкого

Авторы:

Белоусов А.С.

Подробнее об авторах

Журнал: Non nocere. Новый терапевтический журнал. 2025;(10): 22‑26

Прочитано: 204 раза

Связаться с автором

Оглавление

Как цитировать:

Белоусов А.С. Доля легкого. Non nocere. Новый терапевтический журнал. 2025;(10):22‑26.
Belousov AS. Lung lobe. Non Nocere. New Therapeutic Journal. 2025;(10):22‑26. (In Russ.)

Использование инфографики авторами научных работ

Литература / References:

Ocrospoma S, Anzueto A, Restrepo MI. Advancements and challenges in the management of pneumonia in elderly patients with COPD. Expert Rev Respir Med. 2024 Dec;18(12):975-989. https://doi.org/10.1080/17476348.2024.2422961
Lineros R, Fernández-Delgado L, Vega-Rioja A, et al. Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids. Biomedicines. 2023 Apr 22;11(5):1243. https://doi.org/10.3390/biomedicines11051243
Weyand CM, Goronzy JJ. Aging of the Immune System. Mechanisms and Therapeutic Targets. Ann Am Thorac Soc. 2016 Dec;13 Suppl 5(Suppl 5): S422-S428. https://doi.org/10.1513/AnnalsATS.201602-095AW
Fan Y, Yao Q, Liu Y, Jia T, Zhang J, Jiang E. Underlying Causes and Co-existence of Malnutrition and Infections: An Exceedingly Common Death Risk in Cancer. Front Nutr. 2022 Feb 23;9:814095. https://doi.org/10.3389/fnut.2022.814095
Rubin DB, Ahmad HA, O’Neal M, et al. Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials. Int J Chron Obstruct Pulmon Dis. 2018 Jan 8;13:189-201. https://doi.org/10.2147/COPD.S142530
Liu DS, Han XD, Liu XD. Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease. Chin Med J (Engl). 2018 May 5;131(9):1086-1091. https://doi.org/10.4103/0366-6999.230727
Gómez-Junyent J, Garcia-Vidal C, Viasus D, et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. PLoS One. 2014 Aug 28;9(8):e105854. https://doi.org/10.1371/journal.pone.0105854
Sellares J, López-Giraldo A, Lucena C, et al. Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia. Am J Respir Crit Care Med. 2013 Jun 1;187(11):1241-1248. https://doi.org/10.1164/rccm.201209-1732OC
Pizzini A, Lunger F, Sahanic A, et al. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations. COPD. 2017 Jun;14(3):298-303. https://doi.org/10.1080/15412555.2016.1266317
Crisafulli E, Menéndez R, Huerta A, et al. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD. Chest. 2013 Apr;143(4):1009-1017. https://doi.org/10.1378/chest.12-1684
Zaki HA, Hamdi Alkahlout B, Shaban E, et al. The Battle of the Pneumonia Predictors: A Comprehensive Meta-Analysis Comparing the Pneumonia Severity Index (PSI) and the CURB 65 Score in Predicting Mortality and the Need for ICU Support. Cureus. 2023 Jul 29;15(7):e42672. https://doi.org/10.7759/cureus.42672
Ahmed N, Jawad N, Jafri S, Raja W. DECAF versus CURB 65 to Foresee Mortality among Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Cureus. 2020 Jan 9;12(1):e6613. https://doi.org/10.7759/cureus.6613
Hunold KM, Schwaderer AL, Exline M, et al. Diagnosing Dyspneic Older Adult Emergency Department Patients: A Pilot Study. Acad Emerg Med. 2021 Jun;28(6):675-678. https://doi.org/10.1111/acem.14183
Claessens YE, Debray MP, Tubach F, et al. Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia. Am J Respir Crit Care Med. 2015 Oct 15;192(8):974-982. https://doi.org/10.1164/rccm.201501-0017OC
Waterer GW. The Diagnosis of Community-acquired Pneumonia. Do We Need to Take a Big Step Backward? Am J Respir Crit Care Med. 2015 Oct 15;192(8):912-913. https://doi.org/10.1164/rccm.201507-1460ED
Reynolds D, Kollef M. The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update. Drugs. 2021 Dec;81(18):2117-2131. https://doi.org/10.1007/s40265-021-01635-6
Recio R, Mancheño M, Viedma E, et al. Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence. Antimicrob Agents Chemother. 2020 Jan 27;64(2): e01759-19. https://doi.org/10.1128/AAC.01759-19
Henig O, Kaye KS. Bacterial Pneumonia in Older Adults. Infect Dis Clin North Am. 2017 Dec;31(4):689-713. https://doi.org/10.1016/j.idc.2017.07.015
Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2016 Sep;48(3):683-693. https://doi.org/10.1183/13993003.01967-2015